蓝帆医疗：Lithonic冠脉血管内冲击波治疗系统获CE认证

Core Viewpoint - The company, Bluestar Medical (002382.SZ), announced that its subsidiary, Biosensors Interventional Technologies Pte. Ltd., has received CE certification for the Lithonic coronary intravascular shockwave treatment system, which is designed to treat severely calcified stenosis areas [1][1]. Group 1 - The Lithonic system is intended for use in areas of severe calcification where balloon dilation or stent expansion is insufficient [1][1]. - The system operates by releasing high-pressure shockwaves to pre-treat calcified lesions, utilizing an electrolytic effect in a solution medium [1][1]. - The technology aims to directly modify calcified lesions and reduce the risk of complications associated with traditional treatment methods, such as vascular perforation and no-reflow phenomena [1][1].